What is Rimonabant?
Rimonabant is a weight loss drug known as Acomplia in Europe and Zimulti in the United States. The pill helps to cause what loss through appetitie reduction. Rimonabant is the first selective CB-1 receptor blocker to be approved for use anywhere. The drud is currently approved for use in 55 countries, including the EU and has proven to be highly succesful. Depending on what you are looking for in your weight loss regimen, Acomplia might be exactly what you are looking for. This product has also shown some success as an anti-smoking tool. More testing is needed to know the full effect, but there is good potential.